03/13/2026
New multi-site research from Ovation Fertility and .fertility highlights the clinical value of epigenetic s***m quality testing in predicting IUI outcomes.
Using SpermQT, researchers found that molecular markers in s***m may help identify which couples are more likely to benefit from IUI and which may achieve greater success by moving sooner to IVF-ICSI.
Kristin Brogaard, Ph.D., Co-Founder and Chief Scientific Officer of Path Fertility discusses how deeper s***m analysis can support more informed, personalized fertility treatment decisions.